Poland· PL-100382978
EndolucinBeta
A other therapeutic radiopharmaceuticals product containing lutetii chloridum [177lu], registered in Poland by ITM Medical Isotopes GmbH. The same ATC class is registered in 8 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Lutetii chloridum [177lu] is registered in 8 of 19 countries.
Countries holding a registration under ATC V10X (other therapeutic radiopharmaceuticals), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Lutetii chloridum [177lu] · ATC V10X
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Lutetii chloridum [177Lu]
- Manufacturer
- ITM Medical Isotopes GmbH
- Country
- Poland (PL)
- ATC code
- V10X
- ATC class
- OTHER THERAPEUTIC RADIOPHARMACEUTICALS
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin03837000166071
- gtin03837000166088
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V10X
Other therapeutic radiopharmaceuticals, as other registers publish it.
- FinlandEndolucinBetaITM Medical Isotopes GmbH
- DenmarkEndolucinBetaITM Medical Isotopes GmbH
- IcelandEndolucinBetaITM Medical Isotopes GmbH
- CzechiaENDOLUCINBETAITM Medical Isotopes GmbH, Garching
- CzechiaENDOLUCINBETAITM Medical Isotopes GmbH, Garching
- BelgiumEndolucinBeta 40 GBq/mlITM Medical Isotopes
- BelgiumEndolucinBeta 40 GBq/mlITM Medical Isotopes
- IrelandEndolucinBeta 40 GBq/mL radiopharmaceutical precursor, solutionITM Medical Isotopes GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d3d7b1d4-7409-4390-b04c-baa5225a0fe9 GET /v1/drugs/d3d7b1d4-7409-4390-b04c-baa5225a0fe9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Prekursor radiofarmaceutyku, roztwór",
"source": "urpl",
"strength": "40 GBq/ml",
"packaging": "03837000166071 ¦ Rpz ¦ EU/1/16/1105/001 ¦ 119735\n1 fiol. 2 ml\n03837000166088 ¦ Rpz ¦ EU/1/16/1105/002 ¦ 119736\n1 fiol. 10 ml",
"substance": "Lutetii (177Lu) Chloridum 40 GBq/ml",
"common_name": "Lutetii chloridum [177Lu]",
"pl_product_id": "100382978",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about lutetii chloridum [177lu].
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.